XML 94 R37.htm IDEA: XBRL DOCUMENT v3.25.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Taxes [Abstract]  
Schedule of Net Loss (Income) Before Tax on Income The components of the net loss before tax on income were as follows:
   Year ended December 31, 
   2023   2024   2025 
             
Domestic (Israel)  $28,224   $31,065   $42,331 
Foreign   916    679    175 
                
Total  $29,141   $31,744   $42,506 
Schedule of Income Tax Expense

Income tax expense was as follows:

 

   Year ended December 31, 
   2023   2024   2025 
Current:            
Domestic (Israel)  $
-
   $
-
   $
-
 
Foreign   16    6    24 
                
    16    6    24 
                
Deferred:               
Domestic (Israel)   
-
    
-
    
-
 
Foreign   
-
    
-
    97 
                
    
-
    
-
    97 
                
Income tax expense  $16   $6   $121 
Schedule of Deferred Tax Assets

Significant components of the Company’s deferred tax assets are as follows:

 

   December 31, 
   2024   2025 
Deferred tax assets:        
Reserves and allowances  $35   $57 
R&D expenses   1,537    1,976 
Stock-based compensation   254    408 
Lease liability   954    896 
Loss carryforward   5,470    8,432 
           
Total deferred tax assets before valuation allowance   8,250    11,769 
Less - valuation allowance   (7,135)   (10,841)
Total deferred tax assets   1,115    928 
           
Deferred tax liabilities:          
Property and equipment   (96)   (128)
ROU Asset   (1,019)   (897)
Total deferred tax liabilities   (1,115)   (1,025)
           
Net deferred tax assets, net  $
-
   $(97)
Schedule of Company’s Statutory Tax Rate

Upon adoption of ASU 2023-09, Improvements to Income Tax Disclosures, as described in Note 2u, the reconciliation of the amount that would result from applying the Company’s statutory tax rate in Israel to income before income tax expense to the reported amount of income tax expense is as follows:

 

   Year ended December 31, 2025 
   Total   % 
         
Tax at Israel statutory rate   (9,804)   23.00%
Foreign Tax Effects   192    (0.45)%
Change in valuation allowance   2,297    (5.39)%
Nontaxable or Nondeductible Items:          
Share-based payment awards   2,399    (5.63)%
Warrants remeasurements   502    (1.18)%
Nondeductible interest expenses   86    (0.20)%
Preferred Technology Enterprise tax effect   4,748    (11.14)%
Other Adjustments   (541)   1.27%
           
Effective tax rate  $121    0.28%